Is It a Good Idea for Circor to Reject Crane’s Bid?

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Is It a Good Idea for Circor to Reject Crane’s Bid?

© littlehenrabi / Getty Images

Circor International Inc. (NYSE: CIR) shares were crushed on Monday on news that the firm’s board of directors had unanimously rejected a buyout bid. Specifically, this was a revised acquisition bid from Crane Co. (NYSE: CR | CR Price Prediction).

The board believes that the bid substantially undervalued the company and was low-value, highly conditional and opportunistic. As a result, the board unanimously recommends that Circor shareholders not tender their shares into Crane’s revised offer.

Crane said that it will not extend its tender offer for Circor shares, which is scheduled to expire at midnight E.T. on July 19. Also, this revised buyout bid for Circor is currently valued at $48 a share, up from $45 a share in the previous week.

It’s worth noting that the current bid implies upside of 40% from the current 200-day moving average ($34.34) and upside of 16% from the 50-day moving average ($41.41).

[nativounit]

David F. Dietz, chair of the board, commented:

After consulting with our financial and legal advisors, it is clear that Crane’s revised unsolicited tender offer substantially undervalues Circor and our go-forward plan for the business. The Circor Board and management team are focused on executing our strategy so we can deliver enhanced value to our shareholders and build a stronger, more resilient business with an improved growth and margin profile. We are confident that our plan will create greater value for our shareholders that is well in excess of Crane’s offer.

Shares of Circor traded down 14% Monday morning to $36.53, in a 52-week range of $19.73 to $48.70. The consensus price target is $50.00.

Crane traded up 0.3% at $83.38. The 52-week range is $67.18 to $100.14, and the consensus price target is $104.14.

[recirclink id=560284]
[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618